Your browser doesn't support javascript.
loading
Pro-angiogenic TIE-2-expressing monocytes/TEMs as a biomarker of the effect of sorafenib in patients with advanced hepatocellular carcinoma.
Shoji, Hirotaka; Yoshio, Sachiyo; Mano, Yohei; Doi, Hiroyoshi; Sugiyama, Masaya; Osawa, Yosuke; Kimura, Kiminori; Arai, Taeang; Itokawa, Norio; Atsukawa, Masanori; Aoki, Yoshihiko; Fukai, Moto; Taketomi, Akinobu; Mizokami, Masashi; Kanto, Tatsuya.
Afiliación
  • Shoji H; Department of Liver Disease, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan.
  • Yoshio S; Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Mano Y; Department of Liver Disease, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan.
  • Doi H; Department of Liver Disease, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan.
  • Sugiyama M; Department of Liver Disease, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan.
  • Osawa Y; Department of Genome Medical Sciences Project, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan.
  • Kimura K; Department of Hepatology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hosptital, Tokyo, Japan.
  • Arai T; Department of Hepatology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hosptital, Tokyo, Japan.
  • Itokawa N; Division of Gastroenterology, Department of Internal Medicine, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.
  • Atsukawa M; Division of Gastroenterology, Department of Internal Medicine, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.
  • Aoki Y; Division of Gastroenterology, Department of Internal Medicine, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.
  • Fukai M; Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Kohnodai Hospital, Ichikawa, Japan.
  • Taketomi A; Department of Genome Medical Sciences Project, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan.
  • Mizokami M; Department of Genome Medical Sciences Project, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan.
  • Kanto T; Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Int J Cancer ; 141(5): 1011-1017, 2017 09 01.
Article en En | MEDLINE | ID: mdl-28555943
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Biomarcadores de Tumor / Niacinamida / Carcinoma Hepatocelular / Receptor TIE-2 / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Biomarcadores de Tumor / Niacinamida / Carcinoma Hepatocelular / Receptor TIE-2 / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Japón